Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,614 USD | -4,79% | -7,37% | -61,07% |
Omzet 2024 * | 14,36 mln. 13,21 mln. | Omzet 2025 * | 27,77 mln. 25,54 mln. | Marktkapitalisatie | 52,12 mln. 47,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -47 mln. -43,23 mln. | Nettowinst (verlies) 2025 * | -36 mln. -33,11 mln. | EV/omzet 2024 * | 3,63 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,88 x |
K/w-verhouding 2024 * |
-2,17
x | K/w-verhouding 2025 * |
-
| Werknemers | 79 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,64% |
Recentste transcriptie over BioLineRx Ltd.
1 dag | -4,79% | ||
1 week | -7,37% | ||
Lopende maand | -8,69% | ||
1 maand | -4,51% | ||
3 maanden | -44,69% | ||
6 maanden | -63,83% | ||
Lopend jaar | -61,07% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 63 | 24-05-09 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 24-02-14 |
Avraham Molcho
BRD | Director/Board Member | 66 | 01-01-10 |
Aharon Schwartz
CHM | Chairman | 80 | 01-01-04 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
15-05-24 | 0,6112 | -5,23% | 327 779 |
14-05-24 | 0,6449 | +3,68% | 109 254 |
13-05-24 | 0,622 | -4,60% | 72 109 |
10-05-24 | 0,652 | -4,83% | 123 838 |
09-05-24 | 0,6851 | +3,83% | 158 354 |
uitgestelde koers Nasdaq, 15 mei 2024 om 18:25 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,21% | 111 mld. | |
+10,23% | 106 mld. | |
-12,20% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,94% | 16,81 mld. | |
+38,42% | 12,54 mld. | |
-24,91% | 8,09 mld. |
- Beurs
- Aandelen
- Koers BLRX
- Koers BLRX